Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Longevity Group Co. Ltd. ( (HK:1863) ) just unveiled an announcement.
China Longevity Group Company Limited has called its annual general meeting for 12 June 2026 in Fuzhou, Fujian, where shareholders will review and approve the audited consolidated financial statements and directors’ and auditors’ reports for the year ended 31 December 2025. The meeting will also consider the re-election of executive directors Liu Jun and Jiang Shisheng, the re-election of long-serving independent non-executive director Lau Chun Pong, and the re-appointment of ZHONGHUI ANDA CPA LIMITED as auditors, with the board empowered to set remuneration.
In addition, shareholders will vote on granting the board a general mandate to allot, issue and deal with up to 20% of the company’s issued share capital, excluding treasury shares, outside of rights issues, scrip dividends and existing share schemes. This share issuance authority, if approved, would give the board greater flexibility to raise capital and manage the company’s equity structure, which may affect ownership dilution and future financing options for investors.
More about China Longevity Group Co. Ltd.
China Longevity Group Company Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 1863. The group operates in mainland China with facilities in Fujian province, though the specific industry and product focus are not disclosed in the announcement.
See more data about 1863 stock on TipRanks’ Stock Analysis page.